+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neurointervention Flow-diverting Stent Market - Global Forecast 2026-2032- Product Image
Neurointervention Flow-diverting Stent Market - Global Forecast 2026-2032- Product Image
Sale

Neurointervention Flow-diverting Stent Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6283568
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Flow-Diverting Stents: Executive Overview

Neurointervention flow-diverting stents are endovascular devices used to redirect blood flow away from selected intracranial aneurysms and support progressive thrombosis and vessel healing. Their clinical role is shaped by aneurysm anatomy, rupture status, vessel geometry, antiplatelet management, operator experience, imaging capability, and the availability of alternative treatments such as coiling, stent-assisted coiling, and surgical clipping. Adoption therefore depends on evidence quality, regulatory requirements, reimbursement, hospital infrastructure, and multidisciplinary decision-making rather than on device availability alone.

Clinical Practice Is Shifting Toward Anatomy-Led Treatment

The field is moving toward more individualized treatment selection. Flow diversion has expanded beyond a narrow focus on large or complex aneurysms, while clinicians continue to define its appropriate use in smaller, distal, ruptured, and anatomically challenging lesions. This shift increases the importance of prospective evidence, long-term follow-up, standardized outcome reporting, and careful patient selection. Training, procedural simulation, cerebral angiography capacity, and protocols for managing thromboembolic and hemorrhagic complications remain central to safe implementation.

Artificial Intelligence Strengthens Planning, Imaging, and Follow-Up

Artificial intelligence can support aneurysm detection, segmentation, morphology assessment, treatment planning, device sizing, image co-registration, and surveillance interpretation. Its practical value is highest when integrated into validated clinical workflows with human oversight. Key requirements include representative training data, transparent performance evaluation, cybersecurity, interoperability with imaging systems, and monitoring for bias across populations and scanners. AI is more likely to augment neurointerventional judgment than replace it, particularly where treatment decisions involve rupture status, collateral circulation, antiplatelet risk, and competing therapies.

Regional Dynamics Reflect Uneven Access and Evidence Adoption

North America combines advanced neurovascular centers, established regulatory pathways, and broad access to specialized imaging, although reimbursement and referral concentration can influence availability. Europe benefits from sophisticated tertiary-care networks, with adoption shaped by national health-technology assessment, procurement, and differing clinical guidelines across countries. Asia-Pacific includes highly capable systems alongside substantial variation in access, training, and device registration. Latin America is influenced by imported-device dependence, public-private healthcare differences, and concentration of expertise in major cities. The Middle East is developing specialized centers and referral networks, while procurement and workforce constraints vary across countries. Africa faces the greatest access barriers in many settings, including limited angiography capacity, specialist shortages, and restricted follow-up infrastructure.

Economic and Security Alliances Shape Care Coordination

ASEAN markets show varied regulatory maturity, specialist availability, and access to neurovascular imaging, making regional training and harmonized evidence especially valuable. BRICS countries combine large and diverse patient populations with differing healthcare capacity, domestic manufacturing priorities, and approval systems. The European Union is influenced by shared regulatory structures but retains national differences in reimbursement and service delivery. G7 members generally have mature specialist networks and strong research capabilities, while still facing cost, workforce, and equitable-access challenges. GCC states are investing in advanced hospital infrastructure and specialist services, often using centralized procurement and international partnerships. NATO members span highly diverse healthcare systems, but collaboration in trauma care, preparedness, training, and interoperability can support neurovascular capability.

Country Contexts Highlight Distinct Implementation Priorities

Australia emphasizes centralized specialist care, evidence-based reimbursement, and access across geographically dispersed populations. Brazil faces regional disparities between advanced urban centers and underserved areas, alongside complex public-private delivery. Canada must address long travel distances, provincial variation, and specialist concentration. China is expanding advanced neurointerventional capability while managing regulatory, training, and regional-access differences. France, Germany, Italy, and Spain have strong tertiary-care capacity, with implementation shaped by national procurement, reimbursement, and guideline environments. India combines rapidly developing specialist centers with substantial affordability and access variation. Japan and South Korea have advanced imaging and procedural expertise, with adoption influenced by regulatory review, clinical evidence, and hospital practice patterns. Mexico faces uneven specialist coverage and infrastructure across regions. Russia’s access and supply conditions vary by institution and geography, with implementation also affected by procurement and regulatory circumstances. The United Kingdom relies on specialized referral networks and evidence-led service planning, while the United States has extensive neurointerventional capacity but significant variation in reimbursement, hospital resources, and access.

Leadership Priorities for Safe and Scalable Adoption

Industry leaders should prioritize evidence generation that reflects real-world anatomy, rupture status, comorbidities, and long-term functional outcomes. They should pair device development with operator training, credentialing support, antiplatelet-management protocols, complication registries, and structured post-procedure surveillance. Partnerships with hospitals and health systems should focus on workflow integration, imaging interoperability, equitable referral pathways, and value-based clinical outcomes rather than device placement alone. Leaders should also establish robust quality systems for AI-enabled tools, including validation, explainability, cybersecurity, bias testing, and continuous performance monitoring. Regional strategies should be adapted to local regulatory, reimbursement, workforce, and infrastructure conditions.

Methodology for a Reliable Executive Assessment

This executive assessment uses the defined market scope of neurointervention flow-diverting stents and synthesizes established clinical, regulatory, health-system, and technology considerations. The analysis distinguishes device-specific factors from broader neurointerventional practice and evaluates implementation through regional, economic-group, and country lenses. It avoids unsupported numerical claims and treats differences in evidence, infrastructure, reimbursement, specialist capacity, and patient pathways as core explanatory variables. A full research program should triangulate peer-reviewed studies, clinical guidelines, regulatory documents, hospital protocols, reimbursement policies, registries, and interviews with qualified practitioners, while documenting source dates, inclusion criteria, and uncertainty.

Future Progress Depends on Evidence, Infrastructure, and Equity

Flow-diverting stents are becoming an increasingly important option within multidisciplinary management of selected intracranial aneurysms, but their benefits depend on appropriate anatomy, skilled execution, medical management, and reliable follow-up. The strongest path forward combines rigorous comparative evidence, responsible technology integration, regional workforce development, and transparent quality measurement. Expanding access will require attention to referral systems, reimbursement, imaging infrastructure, and training as much as to device innovation. Leaders that align clinical safety, operational readiness, and equitable delivery will be best positioned to support durable improvements in neurovascular care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neurointervention Flow-diverting Stent Market, by Product Type
7.1. Introduction
7.2. Flow-diverting Stents
7.3. Flow-diverting Stent Systems
7.4. Stent Delivery Systems
7.5. Accessories & Ancillaries
8. Neurointervention Flow-diverting Stent Market, by Material
8.1. Introduction
8.2. Nitinol
8.3. Cobalt-Chromium
9. Neurointervention Flow-diverting Stent Market, by Application
9.1. Introduction
9.2. Intracranial Aneurysm Treatment
9.3. Arteriovenous Malformations (AVMs)
10. Neurointervention Flow-diverting Stent Market, by End User
10.1. Introduction
10.2. Hospitals (General & Specialty)
10.3. Neurointerventional & Neurosurgery Centers
10.4. Ambulatory Surgical Centers
10.5. Diagnostic & Imaging Centers
11. Neurointervention Flow-diverting Stent Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Neurointervention Flow-diverting Stent Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Neurointervention Flow-diverting Stent Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Acandis GmbH
15.2. BALT Group
15.3. Evasc Medical Systems Corp.
15.4. Imperative Care, Inc.
15.5. Johnson & Johnson
15.6. Medtronic plc
15.7. MicroPort Scientific Corporation
15.8. MicroVention, Inc.
15.9. Oxford Endovascular Ltd.
15.10. Penumbra, Inc.
15.11. Perflow Medical
15.12. phenox GmbH
15.13. Rapid Medical Ltd.
15.14. Stryker Corporation
15.15. Wallaby Medical
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Neurointervention Flow-diverting Stent Market, Years Considered for the Study
FIGURE 2. Global Neurointervention Flow-diverting Stent Market, Research Design
FIGURE 3. Global Neurointervention Flow-diverting Stent Market, Research Framework
FIGURE 4. Global Neurointervention Flow-diverting Stent Market, Data Triangulation
FIGURE 5. Global Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Neurointervention Flow-diverting Stent Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Neurointervention Flow-diverting Stent Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Neurointervention Flow-diverting Stent Market Size, by Material, 2025 vs 2032 (%)
FIGURE 9. Global Neurointervention Flow-diverting Stent Market Size, by Material, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Neurointervention Flow-diverting Stent Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Neurointervention Flow-diverting Stent Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Neurointervention Flow-diverting Stent Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Neurointervention Flow-diverting Stent Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Neurointervention Flow-diverting Stent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Neurointervention Flow-diverting Stent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Neurointervention Flow-diverting Stent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Neurointervention Flow-diverting Stent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Neurointervention Flow-diverting Stent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Neurointervention Flow-diverting Stent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Neurointervention Flow-diverting Stent Market Segmentation & Coverage
TABLE 2. Global Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 3. Global Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Flow-diverting Stents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Flow-diverting Stents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Flow-diverting Stents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Flow-diverting Stent Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Flow-diverting Stent Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Flow-diverting Stent Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Stent Delivery Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Stent Delivery Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Stent Delivery Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Accessories & Ancillaries Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Accessories & Ancillaries Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Accessories & Ancillaries Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 17. Global Nitinol Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Nitinol Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Nitinol Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Cobalt-Chromium Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Cobalt-Chromium Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Cobalt-Chromium Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 24. Global Intracranial Aneurysm Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Intracranial Aneurysm Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Intracranial Aneurysm Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Arteriovenous Malformations (AVMs) Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Arteriovenous Malformations (AVMs) Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Arteriovenous Malformations (AVMs) Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 31. Global Hospitals (General & Specialty) Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Hospitals (General & Specialty) Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Hospitals (General & Specialty) Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Neurointerventional & Neurosurgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Neurointerventional & Neurosurgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Neurointerventional & Neurosurgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Diagnostic & Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Diagnostic & Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Diagnostic & Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Neurointervention Flow-diverting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Asia-Pacific Neurointervention Flow-diverting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Asia-Pacific Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 49. North America Neurointervention Flow-diverting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. North America Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 51. North America Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 52. North America Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 53. North America Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 54. Latin America Neurointervention Flow-diverting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Latin America Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 56. Latin America Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 57. Latin America Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 58. Latin America Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Europe Neurointervention Flow-diverting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Europe Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. Europe Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 62. Europe Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 63. Europe Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. Middle East Neurointervention Flow-diverting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Middle East Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 66. Middle East Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 67. Middle East Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Middle East Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 69. Africa Neurointervention Flow-diverting Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Africa Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 71. Africa Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 72. Africa Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 73. Africa Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 74. Global Neurointervention Flow-diverting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. ASEAN Neurointervention Flow-diverting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. ASEAN Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 77. ASEAN Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 78. ASEAN Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 79. ASEAN Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. GCC Neurointervention Flow-diverting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. GCC Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. GCC Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 83. GCC Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 84. GCC Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. European Union Neurointervention Flow-diverting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. European Union Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 87. European Union Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 88. European Union Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 89. European Union Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. BRICS Neurointervention Flow-diverting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. BRICS Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. BRICS Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 93. BRICS Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 94. BRICS Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. G7 Neurointervention Flow-diverting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. G7 Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. G7 Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 98. G7 Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. G7 Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. NATO Neurointervention Flow-diverting Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. NATO Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 102. NATO Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 103. NATO Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. NATO Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 105. Global Neurointervention Flow-diverting Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. United States Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 107. United States Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 108. United States Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 109. United States Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. United States Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Canada Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 112. Canada Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 113. Canada Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 114. Canada Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. Canada Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Mexico Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 117. Mexico Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. Mexico Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 119. Mexico Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. Mexico Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Brazil Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 122. Brazil Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 123. Brazil Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 124. Brazil Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 125. Brazil Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. United Kingdom Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 127. United Kingdom Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 128. United Kingdom Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 129. United Kingdom Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. United Kingdom Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Germany Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 132. Germany Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. Germany Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 134. Germany Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. Germany Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. France Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 137. France Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 138. France Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 139. France Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 140. France Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. Russia Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 142. Russia Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 143. Russia Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 144. Russia Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. Russia Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. Italy Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 147. Italy Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 148. Italy Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 149. Italy Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Italy Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 151. Spain Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 152. Spain Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 153. Spain Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 154. Spain Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Spain Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. China Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 157. China Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. China Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 159. China Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. China Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 161. India Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 162. India Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. India Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 164. India Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. India Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Japan Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 167. Japan Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. Japan Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 169. Japan Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 170. Japan Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Australia Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 172. Australia Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 173. Australia Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 174. Australia Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. Australia Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. South Korea Neurointervention Flow-diverting Stent Market Size, 2017-2032 (USD Million)
TABLE 177. South Korea Neurointervention Flow-diverting Stent Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 178. South Korea Neurointervention Flow-diverting Stent Market Size, by Material, 2017-2032 (USD Million)
TABLE 179. South Korea Neurointervention Flow-diverting Stent Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. South Korea Neurointervention Flow-diverting Stent Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Global Neurointervention Flow-diverting Stent Market Share, by Key Player, 2025
TABLE 182. Global Neurointervention Flow-diverting Stent Market, Key Experts

Companies Mentioned

  • Acandis GmbH
  • BALT Group
  • Evasc Medical Systems Corp.
  • Imperative Care, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • MicroPort Scientific Corporation
  • MicroVention, Inc.
  • Oxford Endovascular Ltd.
  • Penumbra, Inc.
  • Perflow Medical
  • phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Wallaby Medical

Related Topics

Related Reports

Intracranial Stents Market Report 2026 - Product Image

Intracranial Stents Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Neurovascular Stents - Global Strategic Business Report - Product Image

Neurovascular Stents - Global Strategic Business Report

  • Report
  • 191 Pages
  • Global
From
Intracranial Stents Market - Global Forecast 2026-2032 - Product Image

Intracranial Stents Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Self-Expandable Stents - Global Strategic Business Report - Product Image

Self-Expandable Stents - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From
Intracranial Stents Total Addressable Market - Global Forecast 2026-2032 - Product Image

Intracranial Stents Total Addressable Market - Global Forecast 2026-2032

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.